{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:59:51Z","timestamp":1772135991290,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:00Z","timestamp":1510099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:00Z","timestamp":1510099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Trachoma is caused by\n                    <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                    (Ct). It is targeted for global elimination as a public health problem. In 2014, a population-based cross-sectional study was performed in two previously trachoma-endemic areas of The Gambia. Participants of all ages from Lower River Region (LRR) (N\u2009=\u20091028) and Upper River Region (URR) (N\u2009=\u2009840) underwent examination for trachoma and had blood collected for detection of antibodies against the Ct antigen Pgp3, by ELISA. Overall, 30 (1.6%) individuals had active trachoma; the prevalence in children aged 1\u20139 years was 3.4% (25\/742) with no statistically significant difference in prevalence between the regions. There was a significant difference in overall seroprevalence by region: 26.2% in LRR and 17.1% in URR (p\u2009&lt;\u20090.0001). In children 1\u20139 years old, seroprevalence was 4.4% in LRR and 3.9% in URR. Reversible catalytic models using information on age-specific seroprevalence demonstrated a decrease in the transmission of Ct infection in both regions, possibly reflecting the impact of improved access to water, health and sanitation as well as mass drug administration campaigns. Serological testing for antibodies to Ct antigens is potentially useful for trachoma programmes, but consideration should be given to the co-endemicity of sexually transmitted Ct infections.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-15056-7","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T16:03:59Z","timestamp":1509638639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-9040","authenticated-orcid":false,"given":"Stephanie J.","family":"Migchelsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno","family":"Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Gwyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Joof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pateh","family":"Makalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Burr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C. W.","family":"Mabey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony W.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1064-5980","authenticated-orcid":false,"given":"Chrissy h.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"15056_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S2214-109X(13)70113-X","volume":"1","author":"RRA Bourne","year":"2013","unstructured":"Bourne, R. R. A. et al. Causes of vision loss worldwide, 1990\u20132010: A systematic analysis. Lancet Glob. Heal. \n                           1, 339\u2013349 (2013).","journal-title":"Lancet Glob. Heal."},{"key":"15056_CR2","unstructured":"World Health Organization Alliance for the Global Elimination of Trachoma by 2020. Eliminating trachoma: accelerating towards 2020 (2016)."},{"key":"15056_CR3","unstructured":"World Health Organization. Validation of elimination of trachoma as a public health problem (WHO\/HTM\/NTD\/2016.8) (2016)."},{"key":"15056_CR4","unstructured":"WHO. Weekly epidemiological record Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire. World Heal. Organ. Wkly. Epidemiol. Rec. 96, 421\u2013428 (2014)."},{"key":"15056_CR5","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/bjo.84.9.948","volume":"84","author":"H Faal","year":"2000","unstructured":"Faal, H. et al. Evaluation of a national eye care programme: re-survey after 10 years. Br. J. Ophthalmol. \n                           84, 948\u201351 (2000).","journal-title":"Br. J. Ophthalmol."},{"key":"15056_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/bjo.82.8.930","volume":"82","author":"PJ Dolin","year":"1998","unstructured":"Dolin, P. J. et al. Trachoma in the Gambia. Br. J. Ophthalmol. \n                           82, 930\u2013933 (1998).","journal-title":"Br. J. Ophthalmol."},{"key":"15056_CR7","doi-asserted-by":"publisher","first-page":"e2115","DOI":"10.1371\/journal.pntd.0002115","volume":"7","author":"EM Harding-Esch","year":"2013","unstructured":"Harding-Esch, E. M. et al. Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia. PLoS Negl. Trop. Dis. \n                           7, e2115 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"15056_CR8","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1371\/journal.pntd.0000573","volume":"3","author":"EM Harding-Esch","year":"2009","unstructured":"Harding-Esch, E. M. et al. Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020? PLoS Negl. Trop. Dis \n                           3, e573 (2009).","journal-title":"PLoS Negl. Trop. Dis"},{"key":"15056_CR9","doi-asserted-by":"publisher","first-page":"e0004863","DOI":"10.1371\/journal.pntd.0004863","volume":"10","author":"RMR Butcher","year":"2016","unstructured":"Butcher, R. M. R. et al. Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Na\u00efve Trachoma-Endemic Region of the Solomon Islands. PLoS Negl. Trop. Dis. \n                           10, e0004863 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"15056_CR10","doi-asserted-by":"crossref","unstructured":"Butcher, R. et al. Age-specific prevalence of anti-Pgp3 antibodies and severe conjunctival scarring in the Solomon Islands. bioRxiv (2017).","DOI":"10.1101\/141135"},{"key":"15056_CR11","doi-asserted-by":"publisher","first-page":"e0005277","DOI":"10.1371\/journal.pntd.0005277","volume":"11","author":"C Macleod","year":"2017","unstructured":"Macleod, C. et al. Eyelash Epilation in the Absence of Trichiasis: Results of a Population-Based Prevalence Survey in the Western Division of Fiji. PLoS Negl. Trop. Dis \n                           11, e0005277 (2017).","journal-title":"PLoS Negl. Trop. Dis"},{"key":"15056_CR12","doi-asserted-by":"crossref","unstructured":"Zambrano, A. I. et al. TheWorld Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and Added Benefit of Testing for Antibodies to Chlamydia trachomatis pgp3 Protein: NESTS Study. PLoS Negl. Trop. Dis. 10 (2016).","DOI":"10.1371\/journal.pntd.0005003"},{"key":"15056_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/infdis\/130.4.388","volume":"130","author":"S Wang","year":"1974","unstructured":"Wang, S. & Grayston, J. T. Human seroloy in Chlamydia trachomatis: Infection with Microimmunofluorescence. J. Infect. Dis. \n                           130, 388\u2013397 (1974).","journal-title":"J. Infect. Dis."},{"key":"15056_CR14","doi-asserted-by":"publisher","first-page":"e0004352","DOI":"10.1371\/journal.pntd.0004352","volume":"10","author":"SK West","year":"2016","unstructured":"West, S. K. et al. Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey. PLoS Negl. Trop. Dis. \n                           10, e0004352 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"15056_CR15","doi-asserted-by":"crossref","unstructured":"Martin, D. L. et al. Serology for Trachoma Surveillance after Cessation of Mass Drug Administration. PLoS Negl. Trop. Dis. 9 (2015).","DOI":"10.1371\/journal.pntd.0003555"},{"key":"15056_CR16","doi-asserted-by":"crossref","unstructured":"Cama, A. et al. Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati. PLoS Negl. Trop. Dis. 11, [manuscript in press] (2017).","DOI":"10.1371\/journal.pntd.0005863"},{"key":"15056_CR17","doi-asserted-by":"crossref","unstructured":"Goodhew, E. B. et al. CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs. PLoS Negl. Trop. Dis. 6 (2012).","DOI":"10.1371\/journal.pntd.0001873"},{"key":"15056_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep18532","volume":"5","author":"DL Martin","year":"2015","unstructured":"Martin, D. L. et al. Serological Measures of Trachoma Transmission Intensity. Sci. Rep. \n                           5, 18532 (2015).","journal-title":"Sci. Rep."},{"key":"15056_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/sextrans-2015-052067","volume":"91","author":"SC Woodhall","year":"2015","unstructured":"Woodhall, S. C. et al. Can we use postal surveys with anonymous testing to monitor chlamydia prevalence in young women in England? Pilot study incorporating randomised controlled trial of recruitment methods. Sex. Transm. Infect. \n                           91, 412\u20134 (2015).","journal-title":"Sex. Transm. Infect."},{"key":"15056_CR20","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1128\/CVI.00021-09","volume":"16","author":"GS Wills","year":"2009","unstructured":"Wills, G. S. et al. Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection. Clin. Vaccine Immunol. \n                           16, 835\u201343 (2009).","journal-title":"Clin. Vaccine Immunol."},{"key":"15056_CR21","doi-asserted-by":"publisher","first-page":"e0005230","DOI":"10.1371\/journal.pntd.0005230","volume":"11","author":"SJ Migchelsen","year":"2017","unstructured":"Migchelsen, S. J. et al. Defining Seropositivity Thresholds for Use in Trachoma EliminationStudies. PLoS Negl. Trop. Dis \n                           11, e0005230 (2017).","journal-title":"PLoS Negl. Trop. Dis"},{"key":"15056_CR22","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/trstmh\/trw069","volume":"110","author":"N Cocks","year":"2016","unstructured":"Cocks, N. et al. Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji. Trans. R. Soc. Trop. Med. Hyg. \n                           110, 582\u2013587 (2016).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"15056_CR23","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.4049\/jimmunol.1001240","volume":"185","author":"J Wang","year":"2010","unstructured":"Wang, J. et al. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J. Immunol. \n                           185, 1670\u201380 (2010).","journal-title":"J. Immunol."},{"key":"15056_CR24","unstructured":"United Nations Statistics Division. UN: a world of information (2016)."},{"key":"15056_CR25","doi-asserted-by":"crossref","unstructured":"Sep\u00falveda, N., Stresman, G., White, M. T. & Drakeley, C. J. Current mathematical models for analyzing anti-malarial antibody data with an eye to malaria elimination and eradication. J. Immunol. Res. 2015 (2015).","DOI":"10.1155\/2015\/738030"},{"key":"15056_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-14-1","volume":"14","author":"N Sep\u00falveda","year":"2015","unstructured":"Sep\u00falveda, N., Paulino, C. D. & Drakeley, C. Sample size and power calculations for detecting changes in malaria transmission using antibody seroconversion rate. Malar. J. \n                           14, 1\u201314 (2015).","journal-title":"Malar. J."},{"key":"15056_CR27","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1073\/pnas.0408725102","volume":"102","author":"CJ Drakeley","year":"2005","unstructured":"Drakeley, C. J. et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc. Natl. Acad. Sci. USA \n                           102, 5108\u201313 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"15056_CR28","unstructured":"World Health Organization. Report of the 17th meeting of the WHO alliance for the global elimination of blinding trachoma (2013)."},{"key":"15056_CR29","doi-asserted-by":"crossref","unstructured":"Burr, S. E. et al. Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached? PLoS Negl Trop Dis \n                           10 (2016).","DOI":"10.1371\/journal.pntd.0004906"},{"key":"15056_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/bjo.73.2.82","volume":"73","author":"H Faal","year":"1989","unstructured":"Faal, H., Minassian, D., Sowa, S. & Foster, A. National survey of blindness and low vision in The Gambia: results. Br. J. Ophthalmol. \n                           73, 82\u20137 (1989).","journal-title":"Br. J. Ophthalmol."},{"key":"15056_CR31","doi-asserted-by":"publisher","first-page":"e861","DOI":"10.1371\/journal.pntd.0000861","volume":"4","author":"EM Harding-Esch","year":"2010","unstructured":"Harding-Esch, E. M. et al. Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial. PLoS Negl. Trop. Dis. \n                           4, e861 (2010).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"15056_CR32","doi-asserted-by":"publisher","first-page":"e979","DOI":"10.1371\/journal.pntd.0000979","volume":"5","author":"C Chen","year":"2011","unstructured":"Chen, C. et al. Incremental cost of conducting population-based prevalence surveys for a neglected tropical disease: the example of trachoma in 8 national programs. PLoS Negl. Trop. Dis. \n                           5, e979 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"15056_CR33","doi-asserted-by":"crossref","unstructured":"Burton, M. J. et al. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities. PLoS Negl. Trop. Dis. 4 (2010).","DOI":"10.1371\/journal.pntd.0000835"},{"key":"15056_CR34","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(97)01355-X","volume":"349","author":"PJ Dolin","year":"1997","unstructured":"Dolin, P. J. et al. Reduction of trachoma in a sub-Saharan village in absence of a disease control programme. Lancet \n                           349, 1511\u20132 (1997).","journal-title":"Lancet"},{"key":"15056_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/infdis\/170.3.709","volume":"170","author":"RL Bailey","year":"1994","unstructured":"Bailey, R. L. et al. Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities. J. Infect. Dis. \n                           170, 709\u201312 (1994).","journal-title":"J. Infect. Dis."},{"key":"15056_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1017\/S0950268800049815","volume":"108","author":"DC Mabey","year":"1992","unstructured":"Mabey, D. C., Bailey, R. L., Ward, M. E. & Whittle, H. C. A longitudinal study of trachoma in a Gambian village: implications concerning the pathogenesis of chlamydial infection. Epidemiol. Infect. \n                           108, 343\u201351 (1992).","journal-title":"Epidemiol. Infect."},{"key":"15056_CR37","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMc0706263","volume":"358","author":"AW Solomon","year":"2008","unstructured":"Solomon, A. W. et al. Two doses of azithromycin to eliminate trachoma in a Tanzanian community. N. Engl. J. Med. \n                           358, 1870\u20131 (2008).","journal-title":"N. Engl. J. Med."},{"key":"15056_CR38","unstructured":"The Gambia Bureau of Statistics (GBOS) & ICF International. The Gambia Demographic and Health Survey (2014)."},{"key":"15056_CR39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jadohealth.2013.06.004","volume":"53","author":"IS Speizer","year":"2013","unstructured":"Speizer, I. S., Christophe Fotso, J., Davis, J. T., Saad, A. & Otai, J. Timing and Circumstances of First Sex among Female and Male Youth from Select Urban Areas of Nigeria, Kenya, and Senegal. J Adolesc Heal. \n                           53, 609\u2013616 (2013).","journal-title":"J Adolesc Heal."},{"key":"15056_CR40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/OLQ.0b013e3181a866b8","volume":"36","author":"M Ghebremichael","year":"2009","unstructured":"Ghebremichael, M., Larsen, U. & Paintsil, E. Association of age at first sex with HIV-1, HSV-2, and other sexual transmitted infections among women in northern Tanzania. Sex. Transm. Dis. \n                           36, 570\u20136 (2009).","journal-title":"Sex. Transm. Dis."},{"key":"15056_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1728-4465.2008.00174.x","volume":"39","author":"C Sauvain-Dugerdil","year":"2008","unstructured":"Sauvain-Dugerdil, C. et al. The start of the sexual transition in Mali: risks and opportunities. Stud. Fam. Plann. \n                           39, 263\u201380 (2008).","journal-title":"Stud. Fam. Plann."},{"key":"15056_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S0140-6736(82)90273-2","volume":"320","author":"DCW Mabey","year":"1982","unstructured":"Mabey, D. C. W. & Whittle, H. C. Genital and neonatal chlamydial infection in a trachoma endemic area. Lancet \n                           320, 300\u2013301 (1982).","journal-title":"Lancet"},{"key":"15056_CR43","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0140-6736(00)04333-6","volume":"357","author":"G Walraven","year":"2001","unstructured":"Walraven, G. et al. The burden of reproductive-organ disease in rural women in The Gambia, West Africa. Lancet (London, England) \n                           357, 1161\u20131167 (2001).","journal-title":"Lancet (London, England)"},{"key":"15056_CR44","first-page":"150","volume":"102","author":"A Gueye Ndiaye","year":"2009","unstructured":"Gueye Ndiaye, A. et al. [Screening for HIV, syphilis, Chlamydia trachomatis and Neisseria gonorrhoreae during a combined survey conducted in Malicouna, a Senegalese rural area]. Bull Soc Pathol Exot \n                           102, 150\u2013154 (2009).","journal-title":"Bull Soc Pathol Exot"},{"key":"15056_CR45","first-page":"1","volume":"10","author":"L Newman","year":"2015","unstructured":"Newman, L., Rowley, J., Hoorn, S. & Wijesooriya, N. S. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PloS ONEone \n                           10, 1\u201317 (2015).","journal-title":"PloS ONEone"},{"key":"15056_CR46","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1056\/NEJMoa040979","volume":"351","author":"AW Solomon","year":"2004","unstructured":"Solomon, A. W. et al. Mass treatment with single-dose azithromycin for trachoma. N. Engl. J. Med. \n                           351, 1962\u201371 (2004).","journal-title":"N. Engl. J. Med."},{"key":"15056_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0939-1","volume":"14","author":"LL van den Hoogen","year":"2015","unstructured":"van den Hoogen, L. L. et al. Serology describes a profile of declining malaria transmission in Farafenni, The Gambia. Malar. J. \n                           14, 416 (2015).","journal-title":"Malar. J."},{"key":"15056_CR48","doi-asserted-by":"publisher","first-page":"e462","DOI":"10.1371\/journal.pntd.0000462","volume":"3","author":"M Gambhir","year":"2009","unstructured":"Gambhir, M. et al. The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control. PLoS Negl. Trop. Dis. \n                           3, e462 (2009).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"15056_CR49","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/sextrans-2011-050386","volume":"89","author":"PJ Horner","year":"2013","unstructured":"Horner, P. J. et al. Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study. Sex. Transm. Infect. \n                           89, 398\u2013403 (2013).","journal-title":"Sex. Transm. Infect."},{"key":"15056_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-216","volume":"14","author":"EB Goodhew","year":"2014","unstructured":"Goodhew, E. B. et al. Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration. BMC Infect. Dis. \n                           14, 216 (2014).","journal-title":"BMC Infect. Dis."},{"key":"15056_CR51","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/humrep\/17.3.699","volume":"17","author":"AP Gijsen","year":"2002","unstructured":"Gijsen, A. P., Land, J. A., Goossens, V. J., Slobbe, M. E. P. & Bruggeman, C. A. Chlamydia antibody testing in screening for tubal factor subfertility: the significance of IgG antibody decline over time. Hum. Reprod. \n                           17, 699\u2013703 (2002).","journal-title":"Hum. Reprod."},{"key":"15056_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep19472","volume":"6","author":"V Yman","year":"2016","unstructured":"Yman, V. et al. Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity. Sci. Rep. \n                           6, 19472 (2016).","journal-title":"Sci. Rep."},{"key":"15056_CR53","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/pgmj.53.624.595","volume":"53","author":"D Hobson","year":"1977","unstructured":"Hobson, D. & Rees, E. Maternal genital chlamydial infection as a cause of neonatal conjunctivitis. Postgrad.Med.J. \n                           53, 595\u2013597 (1977).","journal-title":"Postgrad.Med.J."},{"key":"15056_CR54","doi-asserted-by":"publisher","first-page":"e0003670","DOI":"10.1371\/journal.pntd.0003670","volume":"9","author":"E Harding-Esch","year":"2015","unstructured":"Harding-Esch, E. et al. Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study. PLoS Negl. Trop. Dis. \n                           9, e0003670 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"15056_CR55","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/09286586.2015.1037401","volume":"22","author":"AW Solomon","year":"2015","unstructured":"Solomon, A. W. et al. The Global Trachoma Mapping Project: Methodology of a 34-Country Population-Based Study. Ophthalmic Epidemiol. \n                           22, 214\u201325 (2015).","journal-title":"Ophthalmic Epidemiol."},{"key":"15056_CR56","unstructured":"Courtright, P. et al. Global Trachoma Mapping Project Training for mapping of trachoma (2015)."},{"key":"15056_CR57","unstructured":"R Development Core Team, R Core Team & R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing (R Foundation for Statistical Computing 2008)."},{"key":"15056_CR58","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"CJ Clopper","year":"1934","unstructured":"Clopper, C. J. & Pearson, E. S. The Use of Confidence or Fiducial Limits Illustrated in the Case of the Binomial. Biometrika \n                           26, 404\u2013413 (1934).","journal-title":"Biometrika"},{"key":"15056_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-SS051","volume":"4","author":"MP Fay","year":"2010","unstructured":"Fay, M. P. & Proschan, M. A. Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. Stat. Surv. \n                           4, 1\u201339 (2010).","journal-title":"Stat. Surv."},{"key":"15056_CR60","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1128\/IAI.00931-13","volume":"82","author":"A Kaneko","year":"2014","unstructured":"Kaneko, A. et al. Characteristic age distribution of Plasmodium vivax infections after malaria elimination on Aneityum Island, Vanuatu. Infect. Immun. \n                           82, 243\u201352 (2014).","journal-title":"Infect. Immun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15056-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:17:14Z","timestamp":1671783434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15056-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15056"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15056-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/149237","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,8]]},"assertion":[{"value":"22 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.G. is employed by the commercial company IHRC, Inc. and is a contractor at the Centres for Disease Control and Prevention. The authors have declared that no competing interests exist.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15040"}}